Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-04 @ 12:01 AM
Study NCT ID:
NCT02965157
Status:
UNKNOWN
Last Update Posted:
2016-11-16
First Post:
2016-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma
Sponsor:
Beijing Biohealthcare Biotechnology Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EY201605-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None